← Leaderboards
Ashraf Fawzy
Johns Hopkins University
$1,367,068
Attributed
$1,367,068
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $319.8K · FY2017–25$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,367,068 · 3
By mechanism
K23$986,363 · 1
R03$245,626 · 1
F32$135,079 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Nadia N Hansel$30,283,781
- Meredith C McCormack$14,784,022
- Laura Marie Paulin$1,678,443
- Patrick N Breysse$2,609,525
- James A Tonascia$68,672,260
Others in their field
Other Emerging Leaders on “Thromboxane B2”
- Robyn Lorraine Woods · Hennepin Healthcare Research Institute$2,052,860
- Uma Reddy · Yale University$1,336,089
- Carrie L Pistenmaa · Brigham And Women'S Hospital$982,810
- Masako Nakanishi · University Of Connecticut Sch Of Med/Dnt$163,625
Research focus
Thromboxane B2FutureQuality Of LifeSymptomsCardiovascular DiseasesComorbidityMortalityPlatelet ActivationRespiratoryResponseCardiovascular SystemRespiratory Signs And SymptomsBiological MarkersInflammationBlood PlateletsMorbidity - Disease RateParticipantPathway InteractionsAlgorithmsIncidenceClinical TrialsInfrastructureIn VivoEndothelium
Grant awards (9)
Platelet Activation Pathways and Respiratory Morbidity in COPD$197,031
K23 · FY2025 · HL · contact PI
Role of platelet-eosinophil interactions in COPD morbidity$122,813
R03 · FY2025 · HL · contact PI
Platelet Activation Pathways and Respiratory Morbidity in COPD$196,475
K23 · FY2024 · HL · contact PI
Role of platelet-eosinophil interactions in COPD morbidity$122,813
R03 · FY2024 · HL · contact PI
Platelet Activation Pathways and Respiratory Morbidity in COPD$197,055
K23 · FY2023 · HL · contact PI
Platelet Activation Pathways and Respiratory Morbidity in COPD$197,623
K23 · FY2022 · HL · contact PI
Platelet Activation Pathways and Respiratory Morbidity in COPD$198,179
K23 · FY2021 · HL · contact PI
The role of platelet activation and particulate matter exposure in COPD morbidity$69,589
F32 · FY2018 · ES · contact PI
The role of platelet activation and particulate matter exposure in COPD morbidity$65,490
F32 · FY2017 · ES · contact PI